Free Trial

Eton Pharmaceuticals (ETON) News Today

Eton Pharmaceuticals logo
$12.78 +0.40 (+3.23%)
(As of 02:41 PM ET)
Eton Pharmaceuticals (ETON) Receives a Buy from Craig-Hallum
Eton Pharmaceuticals, Inc. stock logo
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Significant Increase in Short Interest
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 206,500 shares, a growth of 7.6% from the October 31st total of 191,900 shares. Currently, 0.8% of the company's stock are sold short. Based on an average daily volume of 202,000 shares, the days-to-cover ratio is presently 1.0 days.
Eton Pharmaceuticals, Inc. stock logo
238,565 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by Wasatch Advisors LP
Wasatch Advisors LP purchased a new position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 238,565 shares of the company's stock, valued at approximately $1,43
Eton Pharmaceuticals, Inc. stock logo
What is HC Wainwright's Estimate for ETON FY2024 Earnings?
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Investment analysts at HC Wainwright reduced their FY2024 EPS estimates for shares of Eton Pharmaceuticals in a research report issued to clients and investors on Tuesday, November 26th. HC Wainwright analyst S. Ramakanth now anticipates th
Eton Pharmaceuticals, Inc. stock logo
What is HC Wainwright's Estimate for ETON Q1 Earnings?
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Stock analysts at HC Wainwright decreased their Q1 2025 earnings per share (EPS) estimates for shares of Eton Pharmaceuticals in a note issued to investors on Tuesday, November 26th. HC Wainwright analyst S. Ramakanth now forecasts that the
Eton Pharmaceuticals' (ETON) Buy Rating Reiterated at HC Wainwright
Eton Pharma - Small Cap That's Climbing
Eton Pharmaceuticals, Inc. stock logo
Eton Pharmaceuticals (NASDAQ:ETON) Receives Buy Rating from HC Wainwright
HC Wainwright restated a "buy" rating and issued a $15.00 price target (up previously from $11.00) on shares of Eton Pharmaceuticals in a report on Tuesday.
Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK
Eton Pharmaceuticals, Inc. stock logo
Short Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Drops By 6.2%
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 191,900 shares, a decrease of 6.2% from the October 15th total of 204,600 shares. Based on an average daily trading volume, of 156,700 shares, the days-to-cover ratio is currently 1.2 days. Currently, 0.8% of the company's shares are short sold.
Eton Pharmaceuticals, Inc. stock logo
HC Wainwright Has Bullish Forecast for ETON FY2024 Earnings
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Analysts at HC Wainwright upped their FY2024 earnings per share estimates for shares of Eton Pharmaceuticals in a research report issued on Wednesday, November 13th. HC Wainwright analyst S. Ramakanth now forecasts that the company will ear
Eton Pharmaceuticals, Inc. stock logo
HC Wainwright Brokers Reduce Earnings Estimates for ETON
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for Eton Pharmaceuticals in a research report issued on Wednesday, November 13th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings
Eton Pharmaceuticals Reports Strong Q3 2024 Results
Eton Pharmaceuticals, Inc. stock logo
HC Wainwright Reaffirms Buy Rating for Eton Pharmaceuticals (NASDAQ:ETON)
HC Wainwright reaffirmed a "buy" rating and issued a $11.00 target price on shares of Eton Pharmaceuticals in a report on Wednesday.
Eton Pharmaceuticals reports Q3 EPS 2c, consensus (1c)
Earnings Outlook For Eton Pharmaceuticals
Eton Pharmaceuticals awarded second patent for ET-400
Eton Pharmaceuticals, Inc. stock logo
Eton Pharmaceuticals (ETON) Scheduled to Post Earnings on Tuesday
Eton Pharmaceuticals (NASDAQ:ETON) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports.
Eton Pharmaceuticals (ETON) Gets a Buy from Craig-Hallum
Eton Pharmaceuticals, Inc. stock logo
Craig Hallum Raises Eton Pharmaceuticals (NASDAQ:ETON) Price Target to $15.00
Craig Hallum raised their price target on shares of Eton Pharmaceuticals from $10.00 to $15.00 and gave the stock a "buy" rating in a research report on Monday.
Eton Pharmaceuticals, Inc. stock logo
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Update
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) saw a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 204,600 shares, a growth of 62.0% from the September 30th total of 126,300 shares. Approximately 0.8% of the company's stock are short sold. Based on an average daily trading volume, of 134,300 shares, the short-interest ratio is presently 1.5 days.
Eton Pharmaceuticals, Inc. stock logo
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Major Shareholder Opaleye Management Inc. Purchases 11,248 Shares
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) major shareholder Opaleye Management Inc. acquired 11,248 shares of the business's stock in a transaction on Monday, October 7th. The shares were bought at an average cost of $7.22 per share, with a total value of $81,210.56. Following the completion of the acquisition, the insider now owns 2,730,000 shares in the company, valued at approximately $19,710,600. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
Craig-Hallum Gives a Buy Rating to Eton Pharmaceuticals (ETON)
Eton Pharmaceuticals, Inc. stock logo
Eton Pharmaceuticals (NASDAQ:ETON) PT Raised to $10.00 at Craig Hallum
Craig Hallum raised their target price on Eton Pharmaceuticals from $8.00 to $10.00 and gave the company a "buy" rating in a report on Friday.
Eton Pharma To Buy SPIGFD Drug Increlex From Ipsen
Eton Pharmaceuticals, Inc. stock logo
Aristides Capital LLC Purchases Shares of 200,000 Eton Pharmaceuticals, Inc. (NASDAQ:ETON)
Aristides Capital LLC purchased a new position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 200,000 shares of the company's stock, valued
Get Eton Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter.

Trump’s secret $10T inheritance (Ad)

With the dust now settling on the election… Trump’s true plans for America are starting to take shape. Given all that noise, you might’ve missed Trump’s most important move yet…

Watch now – “America’s New Power Play”

ETON Media Mentions By Week

ETON Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ETON
News Sentiment

-0.03

0.73

Average
Medical
News Sentiment

ETON News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ETON Articles
This Week

7

2

ETON Articles
Average Week

Get Eton Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ETON) was last updated on 12/6/2024 by MarketBeat.com Staff
From Our Partners